Haleon plc (NYSE:HLN) Stake Decreased by Equity Investment Corp

Equity Investment Corp reduced its stake in shares of Haleon plc (NYSE:HLN - Free Report) by 99.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 24,570 shares of the company's stock after selling 3,885,806 shares during the period. Equity Investment Corp's holdings in Haleon were worth $202,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Hexagon Capital Partners LLC raised its holdings in Haleon by 107.3% during the 4th quarter. Hexagon Capital Partners LLC now owns 4,236 shares of the company's stock valued at $35,000 after buying an additional 2,193 shares during the period. Pinnacle Bancorp Inc. boosted its position in Haleon by 853.4% during the fourth quarter. Pinnacle Bancorp Inc. now owns 4,767 shares of the company's stock valued at $39,000 after purchasing an additional 4,267 shares in the last quarter. SRS Capital Advisors Inc. boosted its position in Haleon by 456.4% during the fourth quarter. SRS Capital Advisors Inc. now owns 5,458 shares of the company's stock valued at $45,000 after purchasing an additional 4,477 shares in the last quarter. NBC Securities Inc. bought a new stake in Haleon during the third quarter valued at about $82,000. Finally, Hoxton Planning & Management LLC bought a new stake in Haleon during the fourth quarter valued at about $85,000. 6.67% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HLN has been the topic of a number of recent research reports. Argus reaffirmed a "buy" rating on shares of Haleon in a research report on Tuesday, March 26th. HSBC initiated coverage on Haleon in a research note on Wednesday, April 17th. They issued a "buy" rating for the company. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy".

Haleon Stock Up 1.7 %

Haleon stock traded up $0.14 during midday trading on Friday, reaching $8.51. The company's stock had a trading volume of 11,451,940 shares, compared to its average volume of 5,930,933. The stock's 50-day simple moving average is $8.32 and its 200-day simple moving average is $8.30. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.04 and a quick ratio of 0.73. Haleon plc has a 52-week low of $7.70 and a 52-week high of $8.96. The stock has a market capitalization of $38.86 billion, a P/E ratio of 28.37, a PEG ratio of 2.24 and a beta of 0.28.

Haleon Announces Dividend

The company also recently disclosed a semi-annual dividend, which was paid on Thursday, May 16th. Stockholders of record on Friday, March 15th were paid a $0.1064 dividend. This represents a dividend yield of 1.8%. The ex-dividend date of this dividend was Thursday, March 14th. Haleon's payout ratio is 70.00%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.